26
AstraZeneca PLC announced Tuesday that the European Commission has approved the use of its infection treatment Zavicefta.
The drug, which is used to treat urinary tract infections, pneumonia and other conditions, can now be marketed in all 28 European Union countries as well as Iceland, Norway and Liechtenstein, Astra said.
Source: MarketWatch
